Brokerage Firm Rating on Express Scripts Holding Company (ESRX)

Express Scripts Holding Company (ESRX) : The consensus on Express Scripts Holding Company (ESRX) based on 18 analyst recommendation on the company stock is 2.29, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 8 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 8 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 2 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.

Express Scripts Holding Company (ESRX) : The most positive equity analysts on Express Scripts Holding Company (ESRX) expects the shares to touch $105, whereas, the least positive believes that the stock will trade at $69 in the short term. The company is covered by 13 Wall Street Brokerage Firms. The average price target for shares are $83.54 with an expected fluctuation of $9.85 from the mean.


Company shares have received an average consensus rating of Hold for the current week Express Scripts Holding Company (NASDAQ:ESRX): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $75.83 and $75.71 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $76.37. The buying momentum continued till the end and the stock did not give up its gains. It closed at $76.17, notching a gain of 0.50% for the day. The total traded volume was 2,927,932 . The stock had closed at $75.79 on the previous day.

In a related news,The officer (Senior VP, Supply Chain) of Express Scripts Holding Co., Neville Everett sold 800 shares at $74.11 on May 10, 2016. The Insider selling transaction had a total value worth of $59,288. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.